Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Rapport Therapeutics, Inc. RAPP

Set alert

Price alert · RAPP

All alert types
25.13 USD +0.08 +0.32%

At close · Nov 2

24.96 -0.17 -0.68%

After hours · Nov 2, 4:00 PM ET

Bid
25.08 × 2
Ask
25.13 × 2
24.22 Day range 26.16
22.06 52-week range 52.93
YTD
-17.17%
1 year
-13.14%
Open
25.16
Prev close
25.05
Mkt cap
1.45B
Vol
1.33M
Avg vol
712.76K
EPS
-3.03
P/E
0.00
Div yield
0.00%
More statistics
Low
24.22
High
26.16
Forward P/E
-4.94
Beta
1.40
Short ratio
6.70
Inst. own
96.71%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
36.70
200-d avg
35.65
1y target
68.29

5D chart

Chart tools
Interval
1m5m15m30m

Signals (139)
NameTimeAgo
RSI: OverboughtNov 2, 3:30 PM15 hours ago
SMA: BullishNov 2, 2:40 PM16 hours ago
SMA: BullishNov 2, 2:40 PM16 hours ago
SMA: BearishNov 2, 2:15 PM17 hours ago
SMA: BearishNov 2, 1:50 PM17 hours ago
SMA: BullishNov 2, 1:45 PM17 hours ago
SMA: BullishNov 2, 1:45 PM17 hours ago
SMA: BearishNov 2, 1:35 PM17 hours ago
SMA: BullishNov 2, 1:30 PM17 hours ago
MACD: Buy SignalNov 2, 1:30 PM17 hours ago
MACD: Sell SignalNov 2, 1:20 PM17 hours ago
MACD: Buy SignalNov 2, 12:55 PM18 hours ago
MACD: Sell SignalNov 2, 12:45 PM18 hours ago
SMA: BearishNov 2, 12:20 PM18 hours ago
SMA: BullishNov 2, 12:15 PM19 hours ago
SMA: BearishNov 2, 12:10 PM19 hours ago
MACD: Buy SignalNov 2, 11:50 AM19 hours ago
SMA: BullishNov 2, 11:30 AM19 hours ago
SMA: BearishNov 2, 10:40 AM20 hours ago
SMA: BearishNov 2, 10:40 AM20 hours ago

Newest 20 of 139.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 68.29 +171.7% upside
Target (low)
50.00
Target (mean)
68.29
Target (high)
91.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy15
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 16
  • 1 month ago 13
  • 2 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RAPP analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.22-1.36 – -1.08-0.71-72.1%00.0%12
Next quarter-1.20-1.54 – -0.81-0.72-66.2%66.67K0.0%12
Current year-4.04-4.51 – -3.50-2.86-41.2%20.06M0.0%12
Next year-5.09-6.80 – -3.81-4.04-26.0%0-100.0%12

Upgrades and downgrades

The latest rating changes

RAPP analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026Jones TradingMaintainedBuyBuy
Oct 21, 2026Wells FargoMaintainedOverweightOverweight
Oct 21, 2026GuggenheimMaintainedBuyBuy
Oct 20, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 20, 2026BTIGMaintainedBuyBuy
Oct 15, 2026UBSInitiated—Buy
Oct 15, 2026Wolfe ResearchInitiated—Outperform
Oct 6, 2026GuggenheimInitiated—Buy
Sep 16, 2026BTIGMaintainedBuyBuy
Aug 19, 2026BTIGReiteratedBuyBuy
Aug 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 5, 2026BTIGReiteratedBuyBuy
Jul 16, 2026BTIGReiteratedBuyBuy
Jun 24, 2026Leerink PartnersInitiated—Outperform
May 21, 2026BTIGMaintainedBuyBuy
May 8, 2026BTIGReiteratedBuyBuy
Apr 22, 2026BTIGReiteratedBuyBuy
Mar 11, 2026BTIGMaintainedBuyBuy
Mar 11, 2026Wells FargoMaintainedOverweightOverweight
Feb 2, 2026Wells FargoInitiated—Overweight
Dec 9, 2025HC Wainwright & Co.MaintainedBuyBuy
Dec 8, 2025BTIGReiteratedBuyBuy
Nov 19, 2025BTIGInitiated—Buy
Nov 7, 2025CitizensMaintainedMarket OutperformMarket Outperform
Sep 16, 2025Truist SecuritiesInitiated—Buy
Sep 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 6, 2025HC Wainwright & Co.Initiated—Buy
Jul 8, 2025JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Apr 8, 2025JMP SecuritiesInitiated—Market Outperform
Oct 18, 2024Jones TradingInitiated—Buy